News

Calibr scientists engineered a cytokine protein that has shown evidence of providing neuroprotective effects to Parkinson’s disease patients.

The expanded strategic collaboration will advance several innovative assets across AbbVie’s core therapeutic growth areas including immunology, oncology, neuroscience.

The program grant will support the development of high-affinity antibodies that can target skin and lung infections, as well as sexually transmitted diseases.

Eschenmoser pioneered key reactions in synthetic chemistry and shaped the understanding of how life may have first originated on Earth.

Commencement ceremony will be livestreamed via Zoom and on institute’s Facebook page.

Symposium marks public launch of Center for Antiviral Medicines & Pandemic Preparedness (CAMPP)  to develop new antiviral therapies in preparation for future pandemics.

Calibr transitions investigational compound CLB073 to Gates MRI to advance development.

The three winning teams receive grants to support highly innovative research focused on transforming catalysis, biological imaging, and our understanding of interorgan communication.

2022 year-end roundup: Clinical success and consistent funding validate Calibr’s pioneering approach to drug discovery.

A noted biochemist, Walsh had an enormous impact on academic research, drug discovery and the biopharmaceutical field.

Thirteen scientists were named to Clarivate’s Highly Cited Researchers list: a methodology for identifying the most influential researchers from around the world.  

The $3.8 million award will expand the institute’s research programs aimed at identifying therapeutics for various RNA viruses.

Park’s expertise in high-resolution imaging will enable a detailed look at bacterial pathogenesis.

Miller brings a wealth of experience in genome editing to accelerate potential therapeutics for genetic diseases.

Hollis Cline, Jane Dyson and James Williamson among newly announced members.

World-renowned program is ranked highly for chemistry and biological sciences.

Slack co-founder and CEO Stewart Butterfield to serve as an observer to the Board of Directors. 

Global collaboration seeks to develop potential novel, direct-acting antiviral treatments for COVID-19.

Financial support will fuel fundamental scientific breakthroughs and development of new medicines.

Lerner made major scientific contributions and built Scripps Research into a world-renowned hub of innovative science and medicine.

The annual list represents the “who’s who” of influential researchers who have impacted their field over the past decade.

An agreement has been signed to welcome the Florida branch of the science powerhouse into the research arm of UF’s academic health center.

UF and Scripps Research announced they are in talks to integrate the Florida-based branch of Scripps Research with the research arm of UF’s academic health center.

Lou brings experience as a biopharma industry leader and a champion for accessible healthcare as she carries on the legacy of life partner John C. Martin.